The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial
Busso, C., Fernandez-Sanchez, M., Garcia-Velasco, J. A., Landeras, J., Ballesteros, A., Munoz, E., Gonzalez, S., Simon, C., Arce, J.-C., Pellicer, A.Volume:
25
Language:
english
Journal:
Human Reproduction
DOI:
10.1093/humrep/deq005
Date:
April, 2010
File:
PDF, 392 KB
english, 2010